百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06160 百济神州

已收盘 04-15 16:08:08

190.500

+5.600

+3.03%

最高191.800	最低187.100	成交量564.50万
今开187.800	昨收184.900	日振幅2.54%
总市值2,936亿	流通市值2,717亿	总股本15.41亿
成交额10.72亿	换手率0.40%	流通股本14.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":190.5,"timestamp":1776240488006,"preClose":184.9,"halted":0,"volume":5645014,"delay":0,"changeRate":0.03028664142779878,"floatShares":1426000000,"shares":1541000000,"eps":1.4884449667058361,"marketStatus":"已收盘","change":5.6,"latestTime":"04-15 16:08:08","open":187.8,"high":191.8,"low":187.1,"amount":1072129221,"amplitude":0.025419,"askPrice":190.6,"askSize":7000,"bidPrice":190.5,"bidSize":29900,"shortable":3,"etf":0,"ttmEps":1.4884449667058361,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776303000000},"marketStatusCode":5,"adr":0,"listingDate":1533657600000,"exchange":"SEHK","adjPreClose":184.9,"openAndCloseTimeList":[[1776216600000,1776225600000],[1776229200000,1776240000000]],"volumeRatio":1.409721,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"BOM.HK","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":254.4,"timestamp":1776236400000,"preClose":242.07,"halted":0,"volume":6091800,"delay":0,"premium":"-34.84"},"impliedVol":0.394,"impliedVolPercentile":0.3509},"requestUrl":"/m/hq/s/06160","defaultTab":"news","newsList":[{"id":"2627328932","title":"2025年A股药企薪酬：药明康德李革年薪3998万，百济神州人均薪酬94万","url":"https://stock-news.laohu8.com/highlight/detail?id=2627328932","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627328932?lang=zh_cn&edition=full","pubTime":"2026-04-15 19:00","pubTimestamp":1776250843,"startTime":"0","endTime":"0","summary":"红星资本局4月15日消息，随着年报季到来，A股已有超120家医药企业披露了2025年经营业绩，其员工薪酬也受到关注。红星资本局根据企业年报、数据统计发现，药明康德（603259.SH；2359.HK）创始人李革以3998万元的年薪暂列药企管理层第一，较第二名高出1800多万元，其连续位列A股管理层薪酬榜首。人均薪酬方面，百济神州达到94.63万元，位居第一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153706121691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["399300","BK1610","LU1688375341.USD","LU1719994722.HKD","688235","02359","LU2039709279.SGD","LU0327786744.USD","LU2495084118.USD","603259","SG9999002562.SGD","LU1720050803.USD","LU0417516902.SGD","LU0456842615.SGD","LU1046422090.SGD","ONC","06160","BK1589","BK4588","LU2488822045.USD","LU2328871848.SGD","IE00B0JY6N72.USD","LU1934453819.USD","LU1242518857.USD","LU0588546209.SGD","LU1997244956.HKD","02269","BK1583","LU1979443071.USD","LU0051755006.USD","LU2125910500.SGD","LU0572944931.SGD","LU0348825331.USD","LU0708995583.HKD","LU1969619763.USD","LU0307460666.USD","LU1770034418.SGD","LU0039217434.USD","159982","LU0856984785.SGD","BK1576","LU0320764599.SGD","LU1997245094.SGD","LU2242644610.SGD","LU0043850808.USD","LU1808992512.USD","LU3063872942.SGD","BK4526","LU0516422366.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627407195","title":"百济神州(688235)3月31日股东户数3.52万户，较上期增加6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627407195","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627407195?lang=zh_cn&edition=full","pubTime":"2026-04-15 17:13","pubTimestamp":1776244398,"startTime":"0","endTime":"0","summary":"证券之星消息，近日百济神州披露，截至2026年3月31日公司股东户数为3.52万户，较12月31日增加2161.0户，增幅为6.53%。在化学制药行业个股中，百济神州股东户数高于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.52万户。从股价来看，2025年12月31日至2026年3月31日，百济神州区间跌幅为13.03%，在此期间股东户数增加2161.0户，增幅为6.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500030820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1500","BK1588","LU1251922891.USD","LU1770034418.SGD","LU2328871848.SGD","LU0307460666.USD","LU1303224171.USD","BK0239","LU1719994722.HKD","BK1583","LU0588546209.SGD","LU1969619763.USD","688235","06160","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627415479","title":"百济神州年营收382亿：净利14.6亿 安进与Baker是核心股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2627415479","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627415479?lang=zh_cn&edition=full","pubTime":"2026-04-15 09:52","pubTimestamp":1776217938,"startTime":"0","endTime":"0","summary":"百济神州有限公司（公司代码：688235 公司简称：百济神州）日前发布截至2025年12月31日的财报。财报显示，百济神州2025年营收为382.25亿，较上年同期的272亿增长40.46%；","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260415/6391184353468399959612189.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260415/6391184353468399959612189.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33283/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["ONC","06160","AMGN","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627445534","title":"百济神州(688235.SH)发布2025年度业绩，扭亏为盈至14.61亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627445534","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627445534?lang=zh_cn&edition=full","pubTime":"2026-04-14 21:39","pubTimestamp":1776173982,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布2025年年度报告，报告期内，公司实现营业收入382.25亿元，同比增长40.46%。实现归属于上市公司股东的净利润14.61亿元。2023年1月，根据两项3期试验结果，百悦泽获批用于治疗初治和复发性CLL或SLL成年患者。2024年3 月，百悦泽联合奥妥珠单抗获得FDA加速批准用于治疗R/RFL患者。2025年6月，FDA批准百悦泽的薄膜包衣片剂剂型用于所有已获批适应症。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1770034418.SGD","BK1500","LU0588546209.SGD","BK1588","BK4526","688235","ONC","BK1583","BK4139","LU1251922891.USD","LU1969619763.USD","BK4585","BK4588","LU0307460666.USD","LU2328871848.SGD","06160","BK0239","LU1719994722.HKD","BK1161","LU1303224171.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182723590","title":"百济神州2025年度收入大增四成 首度实现全年盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=1182723590","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182723590?lang=zh_cn&edition=full","pubTime":"2026-04-14 20:59","pubTimestamp":1776171594,"startTime":"0","endTime":"0","summary":"百济神州于2025年度在主营业务与全球化布局方面取得显著进展，财务与经营指标普遍向好。根据年报信息，以下为该公司报告期内的关键表现与结构性变化：。2025年度公司总收入为53.43亿美元，较上一年度的38.10亿美元增长40.2%。公司毛利率进一步提升至约87%，较2024年度的84%有所增加。2025年销售成本增幅低于收入增长，规模效应开始体现。总体而言，百济神州在2025年度实现了从快速扩张到盈利突破的关键转折，收入增长和费用管控推动净利润由负转正。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626195663","title":"百济神州安泰适在中国获得上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2626195663","media":"南方财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626195663?lang=zh_cn&edition=full","pubTime":"2026-04-10 17:26","pubTimestamp":1775813160,"startTime":"0","endTime":"0","summary":"百济神州公司宣布，安泰适?（注射用塔拉妥单抗）经优先审评程序获得国家药品监督管理局（NMPA）附条件批准，用于既往接受过至少2种系统性（包括含铂化疗）失败的广泛期小细胞肺癌（ES-SCLC）成人患者。塔拉妥单抗是首个且目前唯一获批的靶向DLL3和CD3的双特异性T细胞衔接器（TCE）抗体，由百济神州与安进公司（Amgen）共同负责其在中国大陆开发和商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604103701225141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","LU1969619763.USD","BK4585","LU1303224171.USD","BK1588","LU0588546209.SGD","BK4588","LU0307460666.USD","ONC","LU1251922891.USD","IPOS","BK1161","LU1719994722.HKD","06160","LU1770034418.SGD","BK1583","BK4526","BK4139","688235","LU2328871848.SGD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100198023","title":"百济神州更新2026年3月股份变动月报表，股本微幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1100198023","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100198023?lang=zh_cn&edition=full","pubTime":"2026-04-09 19:31","pubTimestamp":1775734291,"startTime":"0","endTime":"0","summary":"百济神州有限公司于2026年4月9日发布截至2026年3月31日的月度权益变动报告。报告显示，公司本月共新增发行741,299股普通股，期末普通股总数从上月的1,425,622,549股增至1,426,363,848股。同期，于上海证券交易所科创板上市的人民币股份数量维持在115,055,260股未变。公司在报告期内未进行任何股份回购或注销活动，库存股数量也无变化。该公告由公司执行董事、主席兼首席执行官欧雷强签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625128969","title":"百济神州(06160)授出合共1.77万股美国存托股份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2625128969","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625128969?lang=zh_cn&edition=full","pubTime":"2026-04-08 17:27","pubTimestamp":1775640476,"startTime":"0","endTime":"0","summary":"百济神州(06160)发布公告，于2026年3月31日，董事会薪酬委员会根据2016期权及激励计划的条款授予154名承授人合共1.77万股美国存托股份受限制股份单位。该等受限制股份单位相当于22.98万股股份，约占本公告之日公司发行股份总数的0.01%。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_23.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_23.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4588","LU1969619763.USD","BK0239","LU1251922891.USD","688235","06160","BK4139","LU1303224171.USD","LU1719994722.HKD","BK1583","LU2328871848.SGD","BK1161","LU1770034418.SGD","BK1500","BK4526","BK4585","LU0588546209.SGD","LU0307460666.USD","BK1588","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624695134","title":"突然杀回来了！创新药ETF大盘点！","url":"https://stock-news.laohu8.com/highlight/detail?id=2624695134","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624695134?lang=zh_cn&edition=full","pubTime":"2026-04-04 11:35","pubTimestamp":1775273728,"startTime":"0","endTime":"0","summary":"图解创新药主题ETF","market":"hk","thumbnail":"https://img3.gelonghui.com/a0989-a422cedf-f15d-459f-90fa-e7074c8daf48.jpg?guru_height=2241&guru_width=3280&guru_size=1441563","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a0989-a422cedf-f15d-459f-90fa-e7074c8daf48.jpg?guru_height=2241&guru_width=3280&guru_size=1441563"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4307632","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_fund_highlight","symbols":["LU1770034418.SGD","BK1588","LU1719994722.HKD","BK1574","BK1161","LU1251922891.USD","BK1500","06978","LU1969619763.USD","LU0588546209.SGD","LU2328871848.SGD","LU1303224171.USD","LU0307460666.USD","BK1583","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624314016","title":"中金：国产创新药产业趋势向好 26年学术领域看点较多","url":"https://stock-news.laohu8.com/highlight/detail?id=2624314016","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624314016?lang=zh_cn&edition=full","pubTime":"2026-04-03 10:41","pubTimestamp":1775184094,"startTime":"0","endTime":"0","summary":"中金主要观点如下：研发效率、临床资源优势禀赋，国产创新BD加速、量价齐升NMPA和医药魔方统计显示，2026Q1国内创新药BD总金额超600亿美元，超过2024全年、接近2025全年水平1/2；且平均首付款和平均交易规模均创历史新高。在MNC的积极推动下，多个中国创新资产有望在2026年步入上市申报阶段；基于对国内企业创新能力的认可，多个早期平台化对外合作交易陆续达成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2778985437.USD","159992","06978","BK1515","LU1303224171.USD","01276","01877","LU2328871848.SGD","LU0561508036.HKD","06938","LU0634319403.HKD","LU2543165471.USD","LU0348783233.USD","LU0359202008.SGD","LU0359201885.HKD","LU0588546209.SGD","LU0348766576.USD","BK1500","09995","LU1023057109.AUD","LU0348784397.USD","LU1961090484.USD","LU1969619763.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","BK1191","BK1583","LU0540923850.HKD","LU0359201612.USD","LU0348825331.USD","LU1720050803.USD","LU1770034418.SGD","IE00B543WZ88.USD","LU0417516902.SGD","LU2488822045.USD","BK1161","09926","06160","LU0348767384.USD","LU1719994722.HKD","IE00BPRC5H50.USD","LU2399975544.HKD","LU0417516738.SGD","LU0417516571.SGD","BK1588","BK1574","LU0348827113.USD","LU1794554557.SGD","LU0348735423.USD","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623373124","title":"【券商聚焦】中信证券：基本医保基金收支和结余整体保持稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=2623373124","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623373124?lang=zh_cn&edition=full","pubTime":"2026-03-31 08:59","pubTimestamp":1774918794,"startTime":"0","endTime":"0","summary":"2026年2月医保支出同比增速回升，收支剪刀差有所收窄。该机构预计在医保基金监管力度持续加大，DRG/DIP精细化管理的推动下，2026年全年基金结余率或将延续此前节奏略有提升。医疗健康产业政策改革进入密集期，建议持续关注政策驱动下的医疗健康产业投资机会。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977773","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1564","IE00B543WZ88.USD","03933","HK0000165453.HKD","BK1100","IE00BPRC5H50.USD","BK1161","LU0307460666.USD","LU0634319403.HKD","LU1255011170.USD","LU2399975544.HKD","BK1147","09926","09688","LU0405327494.USD","LU2148510915.USD","LU2476274308.USD","LU1719994722.HKD","BK1588","02196","01789","BK0276","BK1593","LU1770034418.SGD","06160","02228","BK0012","LU1969619763.USD","LU0405327148.USD","600030","LU0348735423.USD","LU2488822045.USD","01530","06821","02367","BK1191","06030","LU1997245177.USD","BK1617","LU0348783233.USD","BK1583","LU2495084118.USD","LU1303224171.USD","01099","LU1115378108.SGD","LU1328615791.USD","BK1515","LU0348766576.USD","BK0028","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623138721","title":"每周股票复盘：百济神州（688235）2025年盈利2.87亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623138721","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623138721?lang=zh_cn&edition=full","pubTime":"2026-03-29 01:27","pubTimestamp":1774718829,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，百济神州报收于232.69元，较上周的227.57元上涨2.25%。本周，百济神州3月27日盘中最高价报235.5元。百济神州当前最新总市值3586.73亿元，在化学制药板块市值排名2/150，在两市A股市值排名35/5191。本周关注点来自业绩披露要点：百济神州2025年实现净利润约2.87亿美元，扭亏为盈。业绩披露要点百济神州公布截至2025年12月31日止年度业绩，总收入约53亿美元，同比增长40.2%；产品收入达53亿美元，同比增长39.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06160","LU1303224171.USD","688235","BK1588","LU1770034418.SGD","LU0307460666.USD","LU1969619763.USD","BK1500","LU1719994722.HKD","LU1251922891.USD","BK1583","LU2328871848.SGD","BK0239","LU0588546209.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622675072","title":"百济神州（688235）披露续聘2026年度审计机构公告，3月25日股价下跌0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622675072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622675072?lang=zh_cn&edition=full","pubTime":"2026-03-25 22:22","pubTimestamp":1774448542,"startTime":"0","endTime":"0","summary":"截至2026年3月25日收盘，百济神州报收于220.17元，较前一交易日下跌0.43%，最新总市值为3393.74亿元。该股当日开盘222.0元，最高226.0元，最低219.37元，成交额达6.81亿元，换手率为2.66%。近日，百济神州有限公司发布《关于续聘2026年度审计机构的公告》。审计委员会已审议同意，并提请董事会及股东大会追认。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500044020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","LU1969619763.USD","06160","LU1303224171.USD","BK1500","LU1770034418.SGD","688235","BK0239","BK1588","LU1719994722.HKD","LU2328871848.SGD","LU1251922891.USD","BK1583","LU0588546209.SGD","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622206073","title":"百济神州：2025年净利润2.87亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622206073","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622206073?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:10","pubTimestamp":1774440632,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月25日，百济神州公告，2025年收入53.43亿美元，同比增长40.2%；净利润2.87亿美元，上年同期净亏损6.45亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603253684282696.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603253684282696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688235","ONC","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621768777","title":"百济神州跌5.30%，浦银国际证券二周前给出“买入”评级，目标价236.00元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621768777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621768777?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:36","pubTimestamp":1774255005,"startTime":"0","endTime":"0","summary":"今日百济神州跌5.30%，收盘报215.51元。2026年3月9日，浦银国际证券研究员阳景,胡泽宇发布了对百济神州的研报《四季度收入符合预期，2026年催化剂丰富》，该研报对百济神州给出“买入”评级，认为其目标价为236.0元，研报发布时股价为238.49元，预期涨幅为1.04%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中信证券的甘坛焕。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688235","161027","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621095723","title":"【券商聚焦】交银国际：CXO行情持续回暖 料板块估值倍数合理","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095723","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621095723?lang=zh_cn&edition=full","pubTime":"2026-03-23 10:25","pubTimestamp":1774232735,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，多重利好因素共振下，2025年以来CXO行情持续回暖。该机构建议重点关注标的细分赛道成长力、核心能力布局、盈利和订单增长能见度、地缘风险敞口及估值上升空间。基于此，该机构首推药明合联，首次覆盖并重点推荐凯莱英和康龙化成。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","LU0634319403.HKD","BK1141","LU0348766576.USD","IE00BPRC5H50.USD","LU1115378108.SGD","BK1583","03933","LU1794554557.SGD","LU1719994722.HKD","LU2488822045.USD","01789","LU1770034418.SGD","IE00B543WZ88.USD","06160","LU0417516571.SGD","03329","BK1500","BK1207","LU0348784397.USD","LU1303224171.USD","BK1197","BK1588","LU2328871848.SGD","01099","09926","BK1161","06821","BK1593","LU2476274720.SGD","BK1574","09688","LU2399975544.HKD","BK1617","LU0417516738.SGD","LU0348735423.USD","02228","LU0417516902.SGD","BK1585","LU0307460666.USD","LU0348767384.USD","02367","LU0540923850.HKD","02196","BK1191","LU2778985437.USD","02268","LU0348827113.USD","LU2476274308.USD","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620203185","title":"【券商聚焦】中国银河：“十五五”首次将生物医药列为国家新兴支柱产业，持续发力研发创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2620203185","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620203185?lang=zh_cn&edition=full","pubTime":"2026-03-20 09:23","pubTimestamp":1773969824,"startTime":"0","endTime":"0","summary":"“十四五”规划重点关注医药创新产品产业化、医药产业化技术攻关、疫苗和短缺药品供应保障、产品质量升级、医药工业绿色低碳等五大工程，成效斐然，中国创新药获批上市数量由2015年的11款提升至2024年的92款，2024年共有22款国产化药和17款国产生物药获批上市，国产创新药占比提升至42%。“十五五”规划提出健全医疗、医保、医药协同发展和治理机制，生物医药产业首次被列为国家“新兴支柱产业”，战略定位进一步提升。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976888","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK0276","BK1564","BK4588","LU2045819591.USD","02268","BK4581","LU0348767384.USD","LU0561508036.HKD","LU0708995583.HKD","LU1720050803.USD","XBI","02359","LU2125910500.SGD","BK4585","LU2476274308.USD","LU0348825331.USD","LU2778985437.USD","02696","HK0000320223.HKD","SG9999014674.SGD","HK0000306685.HKD","09926","LU0052750758.USD","02162","06881","LU0348735423.USD","LU1969619763.USD","399441","LU0417516571.SGD","LU0196878994.USD","BK1588","BK1161","IE00B543WZ88.USD","LU2328871848.SGD","09995","161726","06160","BK1147","HK0000306701.USD","BK1141","LU1770034418.SGD","LU0540923850.HKD","LU2476274720.SGD","601881","LU0348766576.USD","LU2242644610.SGD","LU0307460666.USD","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619127643","title":"每周股票复盘：百济神州（688235）员工购股计划新一期启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2619127643","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619127643?lang=zh_cn&edition=full","pubTime":"2026-03-15 01:12","pubTimestamp":1773508333,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，百济神州报收于228.68元，较上周的238.49元下跌4.11%。公司公告汇总港股公告：员工购股计划百济神州有限公司根据上市规则第17.06A、17.06B及17.06C条公告2018员工购股计划新一轮认购期。港股公告：翌日披露报表百济神州有限公司于2026年3月11日因执行第五版经修订及重列之2018员工购股权计划，向参与人发行741,299股普通股，每股发行价为162.08港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2328871848.SGD","688235","LU0307460666.USD","LU1969619763.USD","BK1500","BK0239","LU1719994722.HKD","06160","LU0588546209.SGD","LU1303224171.USD","LU1251922891.USD","BK1161","BK1583","BK1588","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618387191","title":"百济神州：合共5.7万股美国存托股份获购买","url":"https://stock-news.laohu8.com/highlight/detail?id=2618387191","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618387191?lang=zh_cn&edition=full","pubTime":"2026-03-12 18:00","pubTimestamp":1773309618,"startTime":"0","endTime":"0","summary":"智通财经讯，百济神州(06160)发布公告，截至2025年9月2日至2026年2月27日之认购期的最后一日，合共5.7万股美国存托股份由4431名参与者根据2018员工购股计划购买。所购美国存托股份涉及的股份数目为74.13万，代表于本公告之日本公司已发行股份总数的约0.05%。本文源自：智通财经网","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312180411954a3586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312180411954a3586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0307460666.USD","BK1161","BK1588","BK1500","LU1969619763.USD","LU1251922891.USD","LU0588546209.SGD","BK1583","LU1303224171.USD","LU1719994722.HKD","LU2328871848.SGD","06160","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618138715","title":"每日卖空追踪 | 百济神州 03月12日卖空量成交65.68万股，卖空比例为12.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618138715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618138715?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304238,"startTime":"0","endTime":"0","summary":"百济神州北京时间03月12日，跌1.45%，卖空量成交65.68万股，较上一交易日增加6.11%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163548a4637616&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163548a4637616&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","LU1770034418.SGD","LU1969619763.USD","LU1251922891.USD","LU1303224171.USD","BK1500","BK1161","LU0307460666.USD","LU1719994722.HKD","LU2328871848.SGD","BK1588","BK1583","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":-0.0139},{"period":"1month","weight":0.0832},{"period":"3month","weight":-0.098},{"period":"6month","weight":-0.0268},{"period":"1year","weight":0.2485},{"period":"ytd","weight":0.0312}],"compareEarnings":[{"period":"1week","weight":0.0301},{"period":"1month","weight":0.016},{"period":"3month","weight":-0.0418},{"period":"6month","weight":-0.0006},{"period":"1year","weight":0.208},{"period":"ytd","weight":0.0094}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"BeOne Medicines AG（原名：BeiGene Ltd）是一家全球肿瘤学公司，致力于为全球癌症患者研发新疗法。该公司产品组合涵盖血液学和实体瘤，致力于开发多样化的新型疗法。其产品包Brukinsa、Tevimbra和Pamiparib。Brukinsa是一种口服的布鲁顿酪氨酸激酶(BTK)小分子抑制剂。Tevimbra是一种人源化免疫球蛋白G4（IgG4）抗程序性细胞死亡蛋白1（PD-1）单克隆抗体，具有高亲和力和对PD-1的结合特异性。Tevimbra旨在最大限度地减少与巨噬细胞上Fc-γ（Fcy）受体的结合，帮助人体免疫细胞检测和对抗肿瘤。该公司正在开发的产品线包括Sonrotoclax、Tarlatamab、Zanidatamab、Blinatumomab、BGB-26808、BGB-R046、BG-68501、BG-C9074、BGB-43395、Xaluritamig等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.027621},{"month":2,"riseRate":0.5,"avgChangeRate":0.032126},{"month":3,"riseRate":0.125,"avgChangeRate":-0.059409},{"month":4,"riseRate":0.5,"avgChangeRate":0.042508},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.052709},{"month":6,"riseRate":0.428571,"avgChangeRate":0.007027},{"month":7,"riseRate":0.857143,"avgChangeRate":0.097108},{"month":8,"riseRate":0.857143,"avgChangeRate":0.058603},{"month":9,"riseRate":0.5,"avgChangeRate":0.025162},{"month":10,"riseRate":0.5,"avgChangeRate":-0.027038},{"month":11,"riseRate":0.625,"avgChangeRate":0.118183},{"month":12,"riseRate":0.125,"avgChangeRate":-0.07577}],"exchange":"SEHK","name":"百济神州","nameEN":"BEIGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}